LB Pharmaceuticals Inc (LBRX)

NGM – Real Time Price. Currency in USD

31.13

-1.56 (-4.79%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-321K

-91K

-4K

-2K

Gross Profit

-321K

-91K

-4K

-2K

Operating expenses (excl. COGS)

-30M

-65M

-11M

-3M

Operating Income

-30M

-65M

-11M

-3M

Non-operating income, total

-12M

Pretax income

-25M

-63M

-6M

-14M

Equity in earnings

Taxes

-1K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-25M

-63M

-6M

-14M

LB Pharmaceuticals Inc (LBRX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

LB Pharmaceuticals Inc (LBRX)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

LB Pharmaceuticals Inc (LBRX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

LB Pharmaceuticals Inc (LBRX)

Income Statement (Annual)

Income Statement (Annual)